Cargando…
The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis
OBJECTIVE: The aim of this study is to analyze the expenditures related to the use of antifungal drugs in patients with hematological malignancies. METHODS: In this retrospective study, the expenditures related to use of antifungal drugs for treatment of invasive fungal infections in patients with h...
Autor principal: | Gedik, Habip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639477/ https://www.ncbi.nlm.nih.gov/pubmed/26622185 http://dx.doi.org/10.2147/CEOR.S92455 |
Ejemplares similares
-
Antibiotic resistance status and its costs in hematological patients: A two-year analysis
por: Gedik, Habip
Publicado: (2017) -
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
por: Gedik, Habip, et al.
Publicado: (2014) -
Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
por: Gedik, Habip, et al.
Publicado: (2014) -
Use of antifungal drugs in hematology
por: Nucci, Marcio
Publicado: (2012) -
Etiological causes of pancytopenia: A report of 137 cases
por: Yokuş, Osman, et al.
Publicado: (2016)